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Background. End Stage Kidney Disease (ESKD) is a global public health problem with an 
enormous economic burden. In resource limited settings like South Africa management of 
End Stage Kidney Diseases is rationed to the most transplantable candidates. Racial and 
socio-economic inequalities in selecting candidates have been documented in a South 
Africa despite the availability of guidelines. No data is available on selection outcomes using 
the current 2010 prioritization guidelines of Western Cape. We audited the outcome of 
patients assessed for the renal replacement therapy at Groote Schuur hospital. 
Methodology. A retrospective analytic study of patients presented to the renal 
replacement therapy committee was conducted in the renal unit of Groote Schuur Hospital. 
Outcome letters, proceedings from the committee meetings and the hospital database 
were sources of data used. All new patients presented between 2008 and 2012 were 
included in the study. Data entry and statistical analysis was done using SPSS v.22. 
Results.  A total of 734 ESKD patients were assessed for renal replacement therapy 
between January, 2008 and December, 2012. During that period, there were 564 new 
patients, of which more than half (53.9%) were not selected for the program. Following the 
introduction of the new prioritization criteria a trend towards increasing number of 
patients presented and accepted was noted. More males were presented (M: F = 1.3) and 
most patients were below the age of 50yrs (n=478, 84.8%). Half of the patients came from 
low socioeconomic areas. There were no significant differences in socio-demographic 
factors before and after introduction of the new guidelines. Clinically they had advanced 
disease with either uremic (n=181, 44.4%) or fluid overload (n=179, 43.9%) symptoms as 
their major presentation. The underlying causes were Hypertension (40.6%), Diabetes 
(14.4%) and chronic Glomerulonephritis (15.8%). Predictors of rejection from the program 
included age above 50 years, unemployment and a poor psychosocial assessment. 
Substance abuse and Diabetes also showed a statistical significant association with the 
likelihood of being rejected. Race and marital status were not predictors. 
Conclusion and Recommendations.  Efforts to allocate more resources should continue in 
view of the loss of young and potential productive life. Advanced presentation of patients 
with ESRD represents challenges in early diagnosis and referral in the current system. 
Community screening programs and improved access to knowledgeable clinicians at the 
primary level is advocated. The use of new selection guidelines have not led to an increase 
in selection inequalities. 
  




The increasing burden of non-communicable diseases worldwide is translating into an 
epidemic of Chronic Kidney Diseases (CKD).[1] CKD is increasingly being recognized as a 
public health problem, as documented by the rising number of patients requiring end stage 
kidney management.[1][2] As most End Stage Kidney Disease (ESKD) data are obtained in the 
high income countries, the 7% annual increment[3] in patients treated for ESKD is likely an 
underestimation of the global burden. 
In developing countries where health systems are already strained by communicable 
diseases, such ESKD patients are challenged in getting appropriate treatment.  Although 
data on ESKD patients in sub Saharan Africa are inadequate, reports suggest these patients 
have few options. While their counterparts in developed countries enjoy the benefits of 
renal dialysis, many patients in sub Saharan Africa die from the effects of uremia.[4][5]  Their 
health systems are constrained by the inadequate resources which include human 
resources, numbers of renal units, transplantation programs and the high cost of care.[6] 
In the few state sponsored programs, a limited number of treatment slots are usually 
allocated depending on the budget. This is based on the economical fact that the three 
ways of working within a budget  and containing the costs is either to increase productivity, 
to decrease quality, or reduce the numbers treated.[7]  
In a setting of resource restriction, selection of patients with the most favorable outcome is 
desired. Committees which perform these assessments and make weighty decisions are 
faced with the challenge of denying life prolonging therapy to some patients. To guide such 
assessment meetings, a set of medical and social criteria have been used to avoid bias. As 
kidney transplantation has the potential to keep the cost of such programs manageable[7], 
all selected patients have to be transplantable.  
A similar scenario exists in South Africa were rationing has been in place since the 
introduction of renal replacement therapy.[8] The situation in the Western Cape serves as an 
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example. The provision of dialysis services in this area is inadequate with an estimated 
shortfall of between 600 to 2000 patients annually.[9]  
In the context of resource constraints, the National department of Health in 1997 
introduced dialysis and transplantation guidelines which emphasized on equitable access to 
treatment for all who require it.[10] 
Despite these guidelines in South Africa, there have been reports of inequality in the 
selection of patients. The dangers of rationing dialysis were demonstrated in one Western 
Cape hospital whereby patients likely to be selected were young and white.[8] Despite these 
shortfalls it is still recommended to have a national guideline for eligibility of renal 
replacement therapy as a means of promoting equity in provision of care.[11] 
 
Amidst objections from some nephrologists[12], the Department of Health of South Africa 
updated the guidelines for chronic dialysis in South Africa in 2009. [13] These guidelines 
focused more on exclusion criteria and not on a prioritization system. To cater for priority 
setting, new guidelines have been published in 2010 for rationing dialysis in Western 
Cape.[9] Patients are classified into three categories which will determine their allocation of 
resources (Appendix 1). As an example a category 1 patient will receive treatment 
regardless of whether the allocated dialysis number is full or not. 
 
Despite these outcome oriented criteria, the unpleasant question of equity still exists 20 
years after the apartheid system. This sensitive issue has the potential of attracting 
negative press to a program.[11] It is thus desirable to appraise the characteristics of patients 
accepted to the program in the light of the new guidelines. This work aims at exploring the 
characteristics and outcomes of patients presented for the chronic renal replacement 
program at Groote Schuur Hospital. 
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2.0 Literature Review 
2.1 Epidemiology of End Stage Kidney disease 
The burden of End stage Kidney disease (ESKD) is increasing globally making Chronic Kidney 
Disease (CKD) a public health problem worldwide. Even though data is lacking in sub-
Saharan Africa [14][15][16], the burden of CKD and therefore ESKD is also projected to rise in 
these developing countries. [17] Among other factors, urbanization, infectious diseases like 
HIV and non-communicable diseases are thought to fuel these projections. High mortality 
of ESKD patients in sub-Saharan countries is expected due to the inadequate infrastructure 
and skilled labor.[3] Even in some centers where therapy is available, mortality remains high 
since treatment is unaffordable. As an example, only 6.8% of the ESKD patients survived on 
Hemodialysis for longer than three months in a Nigerian center.[5] In such a scenario, 
focusing on prevention of CKD is more desirable. Conducting screening activities, early 
diagnosis and addressing risk factors have thus been recommended. [18] 
The major risk factors of Chronic Kidney Disease (CKD) in Africa include Hypertension, 
Glomerulonephritis, HIV infection and Diabetes mellitus.[15] Data from the South African 
renal society reveal a similar pattern among patients receiving dialysis. Hypertension, 
Diabetes and glomerulonephritis were among the most common reported causes of 
ESRD.[19] In a biopsy series aimed at determining the histological diagnoses of ESKD in Cape 
Town, the distribution was similar. Among 144 patients biopsied, the causes found were  
chronic glomerulonephritis was in 31%, Hypertension was in 29.9% and HIV-associated 
Nephropathy (HIVAN) in 12.5%.[4]  
These major etiological causes of CKD often present decades before the onset of Kidney 
diseases. Unfortunately due to poverty, lack of education or poor access to medical care 
patients presents with advanced kidney disease requiring dialysis.[5][20] It is thus not 
surprising as CKD has been associated with poverty.[21] 
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Furthermore, they present at an age when they are expected to be productive members of 
the society. Most present about a decade younger than those in developed countries. [5][20]  
The mean age of dialysis requiring patients is 49yrs in South Africa.[19] 
So, in the setting of resource limitation these CKD patients are faced with economic 
challenges in accessing treatment. To highlight the constraints we take for example South 
Africa, a country with approximately 50 million people is covered with a 2.1 nephrologists 
per million population as compared with 16 nephrologist per million population in the 
United States.[14] Likewise the number of ESKD patients on renal replacement therapy is 
comparably less. The number of dialysis units in South Africa’s public sector and private 
sector as of 2012 were 28 and 163 respectively. Collectively these units treated 8,559 
patients giving a prevalence of renal replacement therapy of 164 per million population. 
The public sector is even more resource limited with a lower prevalence of 73 per million 
population. [19] The inequities extend to include marked differences between the public and 
private sectors. It is estimated that only 12.5% of ESRD patients requiring dialysis in the 
public sector receive treatment in Western Cape, South Africa.[9]  Therefore, in countries 
with state sponsored dialysis programs’, rationing of dialysis combined with a transplant 
program has emerged as the acceptable compromise. 
2.2 History of Rationing Dialysis 
The origin of the current hemodialysis machine comes from Holland. Invention of the 
artificial kidney by Willem Kolff in 1944 was later improved by Belding Scribner and others 
in 1960.[22] This represented a new era in treatment of uremia which started in Seattle 
Artificial Kidney Center at the Swedish Hospital.[23][22] Due to resource limitations, this 
lifesaving treatment could only be available to the chosen few. The hospital’s Admission 
and Policy committee selected patients, and the process was twofold. First a panel of 
nephrologist screened patients who were medically eligible. Patients had to be under the 
age of 45 years, medically stable and emotionally mature. Other criteria included absence 
of longstanding hypertension or vascular disease. Secondly, an anonymous committee of 
six decided on who would be included.[23] Social worth was a major consideration in this 
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‘God committee’ as it was informally termed. This selection method was highly criticized 
after being publicized.[24] Not only was it considered inappropriate but its equity was in 
question. Patients likely to be selected were middle aged, middle class and white men.[25] 
Several other committees[26] across the United States followed these principles, only a few 
would use lottery or first come basis as a selection method. Most relied on traits which 
would ensure adherence to dialysis treatments.[26] 
It was not until 1972 when dialysis became incorporated into Medicare, that widespread 
availability was a reality in United States.[27] Despite this widespread availability, a selection 
criteria consisting of qualitative prognosis, medical benefit, ability to pay and age have been 
used.[28] 
Once an expensive life-saving treatment becomes available for the first time in a country, 
rationing is expected. And hence, the practice of rationing in Europe was inevitable. 
Comparable selection committees were present in Britain. Rationing still continued covertly 
at a time when it was being abandoned in the United States.[29] 
Similarly in South Africa, rationing has been practiced since the introduction of renal 
replacement therapy in the country.[8]  Selection of patients during the apartheid era was 
associated with racial disparities. For 46 years since 1948, the apartheid health policy 
affected blacks through segregation of health services and unequal expenditure on health 
services.[30] Inequalities in distribution of patients on dialysis were thus evident. As an 
example in the year 1994 the overall treatment acceptance rate in South Africa was 17 
patients per million population per year (PPM/yr). And blacks (8.4 PPM/yr) were under 
represented compared to colored (32 PPM/yr), white (41 PPM/yr), or Asians (97 PPM/yr). 
[31] In the new South Africa, the government has aspired to provide equitable access to 
health care.[30][32] 
However, realizing these aspirations has been challenging. The deficit in skilled personnel 
and insufficient budget allocation has made rationing of dialysis an unavoidable option. 
Hospital committees have evolved to ensure equity in patients selected onto their dialysis 
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programs. To guide these committees, criteria consisting of both medical and social aspects 
have been used and formalized by the government. In the Western Cape, a renal 
replacement therapy (RRT) committee is composed of at least a nephrologist, social worker 
and a doctor in charge of the case.[9] Suitability for kidney transplantation is the main 
underlying criteria. 
Moosa and others looked at the outcome of one Assessment committee in Western Cape.[8] 
More than half of 2442 patients assessed between 1988 and 2003 were not accepted for 
treatment. Those accepted were likely to be below 40 years of age, white, employed, 
married, non-diabetic and lived in proximity to a dialysis center. Social factors associated 
with poverty were the main cause of denial of treatment in this hospital. These unfortunate 
outcomes are similar to those seen in 1960s in the USA. 
One could question the criteria in place. Does targeting a transplantable individual lead to 
inequality in care provision? A review of the guideline would be informative. 
2.3 Guidelines for the Renal Replacement Program in South Africa 
It is  recommended to have a national guideline for eligibility of renal replacement therapy 
as a means of promoting equity in provision of care.[11] The National department of Health 
in 1997 produced dialysis and transplantation guideline which emphasized on equitable 
access to treatment for all who require it.[10] 
 
Late in 1997, these guidelines were challenged in the Constitutional Court of South Africa. 
Mr. Soobramoney was a 41 years old diabetic who was denied dialysis because of advanced 
vascular disease. According to the guidelines, his advanced vascular disease excluded him 
from the state funded dialysis and transplantation program in Durban. He based his 
argument on section 27(3) of the 1996 South African Constitution which states “No one 
may be refused emergency medical treatment” and section 11 which stipulates “Everyone 
has the right to life”. The judgment was in favor of the Ministry of Health. Mr. 
Soobramoney’s medical condition was judged as a chronic and furthermore it was argued 
that interpretation of section 27(3) should be made in the context of 27(1) and 27(2). These 
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outline the state’s obligation to provide health care services to all. And in 27(2), it is 
stipulated that these provisions are limited by the available resources, given the high cost 
of dialysis.[32] The ruling, in addition acknowledged the use of guidelines in selection of 
candidates. In this manner it strengthened the legal basis of the document.[33] 
 
In  2009 the department of health updated the guidelines for chronic dialysis in South 
Africa.[13] These guidelines had more exclusion criteria and allowed stable HIV positive 
patients to be included in the chronic dialysis programs. 
Current guidelines in Western Cape were published in 2010 for rationing chronic dialysis. [9] 
Under these new guidelines the basis of selection includes the following three elements as 
described in the guideline.[9] ‘Firstly, all patients accepted for renal replacement therapy 
must therefore be eventually suitable for transplantation. Secondly, the allocation of the 
scarce resource must be done in such a way as to maximize the benefit that the society will 
eventually derive from such an allocation (utilitarianism). Thirdly, once transplanted, 
patients should be capable of reliably taking care of themselves and their grafts to ensure 
the optimal survival of the organ.’  
 
Both the abovementioned elements have strong socio-economic connotations. So despite 
the earlier reports of inequality, the new guideline will most likely continue to marginalize 
the socioeconomically disadvantaged population. Utilitarianism ensures maximum benefit 
from the candidate selected. Meaning if transplanted, the candidate will survive the 
longest. Equity means everyone who benefits from therapy should have comparable chance 
to receive it. Unfortunately utilitarianism and equity are opposing principles.[34]  So by 
design, these guidelines will suffer in equity. Which means not everyone who benefits from 
the renal replacement therapy will have a comparable opportunity. These unfortunately, 
are the realities of resource limitation. 
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The positive side of these new guidelines is the introduction of a prioritization policy 
(Appendix 1) which should theoretically increase the number of treated patients. Patients 
are classified into three categories which will determine the allocation of resources. As an 
example a category 1 patient will receive treatment regardless of whether the allocated 
dialysis number is full or not. To qualify as a category 1 patient one has to be less than 50 
years with a body mass index of less than 30kg/m2 and have no category 2 criteria. 
Category 2 criteria include conditions that reduce the candidate’s suitability for transplant 
eg. Diabetes, Hypertension with severe target organ damage, stable HIV and hepatitis 
infection and others as outlined in Appendix 1. These category 2 patients will be offered 
treatment when resources are available. And a category 3 patient will be offered 
conservative therapy. Category 3 candidates are unlikely to benefit from Kidney 
transplantation due to unacceptable mortality and morbidity risk. 
 
In comparison with the guidelines before 2010 (Table 1), one should hypothetically be able 
to predict the outcome of patients presented. The introduction of new guidelines on one 
hand narrows the eligible population by placing an age restriction particularly in diabetics, 
on the other hand, prioritization policy could increase the number of patients treated. In 
Groote Schuur, the latter is more likely to be true. This is because the guidelines used in 
Groote Schuur Renal Replacement Therapy (RRT) committee resemble the new Western 
Cape guidelines. In 2008 the Groote Schuur RRT committee developed an assessment tool[4] 
which later evolved into the current categorization criteria (Appendix 4). 
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Table 1: Comparison of Western Cape Guidelines (2010) with the Department of 
Health Guidelines (2009). 
Aspect Western Cape Guidelines
[9]




Principles Patients must be suitable for 
transplantation 
Transplantation a major criterion 
Guide on modality of chronic dialysis 
not stated. 
Patient and family should be allowed to 
choose the modality of chronic dialysis 
Selection 
criteria 
Both inclusion and exclusion criteria 
used for selection 
Exclusion rather than inclusion criteria 
applied for selection 
Medical Medical exclusion criteria include 
active malignancy and advanced 
irreversible progressive disease of vital 
organs 
Medical exclusion criteria include active 
malignancy and advanced irreversible 
progressive disease of vital organs 
Diabetes will be considered below the 
age of 50years. Comorbid diseases 
may be considered. 
Diabetes and acceptable comorbidity may 
be considered 
Hepatitis B e Antigen positivity to be 
excluded 
Hepatitis B e Antigen Not specified 
Morbid obesity BMI>35 to be excluded BMI limits not specified 
Age above 60yrs are excluded No age limit stated 
Psychosocial Mental illness with diminished 
functional capacity as shown by 
psychiatric and medical examination. 
Mental illness with diminished functional 
capacity 
Habitual non adherence with any 
medical treatment 
Habitual non-compliance with dialysis 
treatment and lifestyle modification. 
 
Evidence for the Selection Criteria 
The cost of dialysis in South Africa is high and hence limited slots are available in state 
sponsored programs. Therefore selection of patients for the renal replacement therapy 
should be based on predicting outcomes after transplantation. The factors that are known 
to be associated with survival after transplantation are diverse and include social and 
medical aspects. 
Socio-demographics and economic factors 
Older age has been associated with decreased survival rates after kidney transplantation. 
There is a significant decline in survival after the age of 60 years.[35] As an example, the 5-
year survival of a non-diabetic candidate aged 56 years is 86% versus 81% if 61yrs  receiving 
a cadaveric kidney transplant.[36] However data from South Africa suggests 40 years as the 
age which demonstrated the most striking difference in survival.[37] 
Several investigators have reported racial disparities in patient survival, whereby it was 
noted that the black population had a poorer survival rate compared to non-black 
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population.[38][39][35] According to the United States organ procurement and transplantation 
data, the 5 year survival of blacks is 61% compared to 74% among whites.[40] Such 
disparities may be explained by immunological differences or by socioeconomic 
differences.[35]  
However, racial differences in transplant survival tend to disappear when controlled for 
socioeconomic status.[41] [42] This fact becomes obvious in the South African setting were 
race was not found to be a determinant in transplant survival.[37] As the selection guideline 
in South Africa ensures a minimum acceptable socioeconomic status, racial differences 
attributed to socioeconomic factors will likely be insignificant. 
Another social criterion considered is substance abuse. Active substance use or dependency 
is used as a strict exclusion criterion. Poor treatment compliance, infection risk and 
continued organ damage have been cited as reasons for unfavorable transplant outcomes. 
The KDIGO guideline[43]is silent about substance abuse, however data from the US 
demonstrates a significant increased risk of graft loss.[44] 
Comorbid diseases including Diabetes Mellitus 
Medical factors which predict good outcomes are plausible and also evidence based. Data 
from the Canadian Organ Replacement Registry[36] showed that increased comorbidity was 
strongly associated with reduced patient survival. Comorbid diseases used in this registry 
included coronary artery disease, congestive cardiac failure, cerebrovascular accident, 
peripheral vascular disease, dementia and chronic obstructive lung disease. Another 
disease included in the score was Diabetes mellitus. This Canadian registry does justify the 
current criteria of excluding diabetics above the age of 50 years by developing survival 
tables in diabetics and non-diabetics. The 5 year survival of diabetics aged between 50 and 
59 years ranged from 79% to 85% compared to non-diabetics which were from 86% to 90%. 
[36] The basis for this excess higher mortality in diabetic patients relates with sepsis and
cardiovascular mortality in the transplanted patient. 
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Obesity and cardiovascular risk in transplantation 
Kidney transplant recipients are at an increased cardiovascular risk [45] due to the associated 
immunosuppression exposure, new onset diabetes and a chronic inflammatory state.[46] 
Obesity has also been associated with increased delayed graft function and short-term 
mortality.[47] It would hence be reasonable to accept patients with reduced cardiovascular 
risk to begin with. Therefore, the guidelines require all patients to have a BMI of 35kg/m2 
and below. Patients below 30kg/m2 would be considered for the category one status. 
The measurement of waist circumference has been demonstrated to predict atherogenesis 
more accurately. Furthermore there is evidence to suggest that waist circumference (a 
measure of visceral obesity) predicts post-transplant outcomes better than BMI.[47] 
Smoking 
Smoking is preventable cause of morbidity and mortality. Although the mechanism of 
kidney damage is not entirely clear, it has been associated with hypertension, diabetes and 
hence a major cardiovascular risk. Data from the United States illustrate the increased 
mortality (hazard ratio of 2.32) of smoking after transplantation.[48] 
Human Immunodeficiency Virus 
Another condition which causes a high mortality and morbidity in South Africa is HIV/AIDS. 
Over the past decade the survival of HIV positive patients has improved. Although there has 
been a decrease in the traditional causes of death from AIDS, an increase in mortality from 
non-communicable diseases in HIV has been observed. HIV associated nephropathy is now 
an important cause ESRD in South Africa.[15] In a biopsy series from Cape Town, HIV 
increased from 6.6% in 2000 to 25% in 2009.[49] Before 2008, patients with ESRD due to HIV 
were not being accepted onto the renal replacement program[50][51] because there was no 
data on their survival outcomes with transplantation. However, it was later shown that 
patients with stable HIV disease had similar renal transplant outcomes as HIV negative 
patients.[52][53][54][51] Currently, HIV is no longer considered as a contraindication for kidney 
transplantation[55] as long as patients have controlled disease. Eligible patients are those 
with a CD4+ T cell count above 200/ml, have an undetectable viral load and, if on 
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antiretroviral (ARV) treatment, have demonstrated good adherence and clinical response 
within 6 months prior to assessment. In 2009 the South African department of health 
issued guidelines which accepted stable HIV positive patients onto the renal replacement 
therapy program.[13] 
Hepatitis Virus 
The program requires patients who have hepatitis be free from cirrhosis and be on 
treatment. This stems from data showing increased mortality in untreated patients. Data 
from France looking at 1238 kidney transplant patients for 10 years demonstrates clearly an 
increased mortality in patients infected with either hepatitis B or C.[56] 
Habitual Non-adherence with any medical treatment 
Compliance to treatment is paramount to the survival of the graft because of the 
associated rejection risk.[43] History of non-compliance is used as an exclusion criterion for 
acceptance onto the Western Cape program.  Pre-transplant non-adherence has been 
shown to predict post-transplant non-adherence with an odds ratio of 7.9.[57] 
  




Treatment of end stage kidney disease carries a huge economic burden even in developed 
countries. In emerging economies like South Africa with a gross domestic product per capita 
of 6,617 USD, dialysis is expensive. Unsubsidized patients in the South African state sector 
would pay about 16,000 USD/year and 17,000 USD/year in private. So in states with 
programs which have limited treatment spaces, rationing of dialysis is inevitable. In South 
Africa, guidelines in rationing dialysis are necessary to enable hospitals to select the most 
appropriate candidates. New guidelines were produced by the Western Cape in 2010. This 
audit documents the outcome of rationing dialysis in the light of the new guidelines. In this 
documentation marginalization of certain patient groups was also assessed. Information 
obtained should help in strengthening the current guideline. Comparing data derived from 
the era prior to the implementation of these guidelines has helped appraise their fairness.  
This work has also shed light on the need for policy makers to allocate resources to the care 
of ESKD. 
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4.0 Study Aims and Objectives 
 
Broad objective 
To assess the outcomes of patients presented to the renal replacement committee at 
Groote Schuur Hospital. 
Specific objectives 
1. To describe the socio-demographic characteristics of patients presented 
2. To describe the clinical characteristics of patients presented 
3. To determine the factors associated with selection of patients onto the program 
4. To compare the characteristics of patients selected before and after 
implementation of the current guidelines 
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5.0 Research Design and Methodology 
 
5.1 Study Design.  
 
This was a retrospective analytic study in which characteristics and outcomes of patients 
assessed by the renal replacement therapy (RRT) committee were recorded from the 
assessment letters.   
5.2 Study population 
 
All new patients presented to the Renal Replacement Therapy Committee at the Groote 
Schuur Hospital from January 1st, 2008 to December 31st, 2012 were included in the audit. 
Groote Schuur is a state owned and tertiary hospital serving half of the Western Cape 
Province. The catchment population consists of a wide range of socio-economic and ethnic 
groups. In 2011, the population in the city of Cape Town was 3.7 million.[58]  Of these, 
females were 51% and the ethnic distribution was as follows Blacks 38.6%, Colored 42.4%, 
Asians 1.4%, Whites 15.7% and others were 1.9%.  
5.2.1 Exclusion criteria 
Excluded from this audit were patients presented for modality change, patients presented 
for transplantation only (Patients accepted for renal replacement therapy elsewhere) and 
patients after transplantation. Other patients excluded were re-assessments and appeals. 
5.3 Assessment of patients for the Renal Replacement Program 
 
The RRT committee convened every Thursday at the renal department of Groote Schuur. 
The composition of a RRT committee included the doctor taking care of the patient, social 
worker and at least 2 Nephrologists. Others included may be the responsible medical 
superintendent or representative, renal unit staff representative and anybody else invited 
by the Chair (6). The Department has an allocation of 148 (plus 5 Hepatitis B positive 
patients) slots for treating ESKD patients.  
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The assessment of eligibility for the renal replacement program was based on the 
information made available to the committee. Patients were presented by the doctor and 
social worker taking care of the patient. The outcome from the RRT committee included 
firstly, the patients’ category and secondly, whether the patient is accepted to start dialysis 
immediately. 
Patients were classified into three categories based on criteria described in Appendix 2. 
After introduction of the prioritization guidelines in 2010, the following prioritization 
categories were used to judge acceptance onto the program. Category 1 patients must be 
accommodated on the dialysis and transplant program. Resources will always be found to 
treat these patients. Category 2 patients will be accommodated on the program only if 
resources allow, with priority given to the category 2 patients waiting the longest and those 
who have the best chance of good outcomes. Category 3 patients will be offered optimal 
conservative treatment and will not be offered renal replacement therapy. 
Before 2010, patients were accepted onto the renal replacement program based on their 
transplantability and no prioritization was made. Nevertheless, from 2008 to 2009 patients 
were classified into 3 categories based on a locally developed assessment tool (Appendix 
4).[14] This earlier version was more comprehensive in terms of the social factors and hence 
not comparable with the new system. To be able to compare the period before and after 
introduction of the new guidelines, the principal investigator classified all new patients 
presented before introduction of the new guidelines. This means that the same criteria to 
categorize patients were used in all periods (Appendix 2) using the 2010 criteria. 
Each candidate presented to the RRT committee had an assessment letter prepared by a 
nephrologist present during the assessment. This letter also contained a summary of the 
psychosocial assessment made by the social worker (Appendix 5). 
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5.4 Data Collection and Management 
Patient’s characteristics and the outcome of the RRT committee were summarized into a 
case record form (Appendix 1). This information was derived from the outcome letter and 
psychosocial assessments produced. These letters were available in the department. 
Additional information was obtained from the proceedings recorded during the meeting. 
Some of the socio-demographic information was obtained from Groote Schuur Hospital 
Clinicom database (Appendix 3). Being accepted as a category 2 patient does not guarantee 
RRT. Information on category 2 patients who eventually got onto the program was obtained 
from the HLA antibody list provided by the National Health Laboratory Services. 
  
The variables included in the Case Record Form were demographic data which included 
age, sex, marital and employment status. Others were race, residence and religion. Clinical 
data collected were the major presenting complaint, body mass index and serology for 
HIV/Hepatitis B surface antigen. Other clinical data recorded were the underlying renal 
diagnosis, co-morbidities and whether the patient required dialysis (late referral). The 
psychosocial data included the assessment of the home conditions, social support and 
insight. History of noncompliance to treatment and history of substance abuse were also 
noted. Outcome variables recorded into the case record form were category of the patient 
and whether the patient was accepted onto the program. 
 
The data from the case record form was then entered into Statistical Package for Social 
Sciences (SPSS) v22.0.0.0.  
 
5.5 Definition of terms (operational definitions) 
 
1. Non-blacks race included whites, Asians and mixed race. 
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2. Ever married included married, divorced and widowed 
 
3. Employed was any candidate who works. This could be self-employment, informal 
or formal employment. 
 
4. Dependents were any person who relied on the candidates support for daily living. 
 
5. Overall psychosocial assessment. A good candidate was one whose psychosocial 
report summary (Appendix 5) by the social worker was positive and deemed fit for 
the program. If the social worker was unable to decide or classified a candidate as 
unfit for the program, the candidate was categorized as Poor 
 
6. Non-compliance any lack of adherence to appointments or medication. 
 
7. Substance abuse. Use of any highly addictive substance excluding nicotine. In the 
case of alcohol, excessive use/dependency had to be demonstrated. 
 
8. Hospital Care Cost. GSH classifies patients according to their ability to pay the 
hospital bills.[59]H0 are pensioners, those on grants and formally unemployed. H1 
are those who earn up to 36,000 rands per annum. H2 those who earn 36,000-
72,000 per annum. H3 above 72,000 rands per annum. Patients classified as Private 
were those charged full patient fees with no subsidized prices. Charged patients 
comprised H1,H2, and H3 patients. In this research protocol patients were classified 
as paying patients or non-paying patients 
 
9. Socio economic status in the Cape Town area. The socioeconomic status of areas 
in Cape Town was mapped in 2001.[60] A socioeconomic status index was based on 
low income, low educational attainment, high unemployment levels and jobs in 
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relatively unskilled occupations. Patients’ area codes were used to classify patients 
as either coming from an area with the worse 20% socioeconomic status index or 
not. 
10. Renal diagnoses. A number of comorbidities/underlying diagnoses were noted. 
These included Hypertension, Chronic glomerulonephritis, Diabetic nephropathy, 
HIVAN, Urological causes, Cystic Kidney disease and interstitial nephritis. Definition 
of these relied on the records as noted by the doctor completing the assessment 
letter. 
5.6 Data analysis and statistical considerations 
 
Before data analysis was attempted, the complete data set was checked for errors. This was 
done by two methods. Firstly, by manually comparing the data with the meeting 
proceedings books, the data was checked for accuracy. Secondly, each variable was re-
checked for errors using descriptive statistics and scatterplots in SPSS. Missing cases were 
noted for some variables. These were excluded in the respective analysis. 
 
The clean dataset in SPSS was summarized into cross tables and bar charts to describe the 
study population. The population was described in three separate time periods. The first 
period was 2008 to 2009 in which no prioritization guidelines were used. In 2010 new 
guidelines were being introduced, some patients were still assessed using the old 
guidelines. The third period was from 2011 to 2012 were the new guidelines were used 
consistently.  
 
 Univariate analysis was performed to assess factors associated with acceptance onto the 
RRT program. Chi square and odd ratios were calculated. The factors which were found to 
be significant were then assessed using logistic regression (multivariate analysis). In both 
instances (univariate and multivariate analysis), a p-value of less than 0.05 was considered 
as significant.  
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In addition, residences were coded based on the patients’ postal code as obtained from 
Groote Schuur Clinicom database. This was then geo-coded using a google geo-coding 
website. This means the latitudes and longitudes were obtained using google. These Geo-
data were then used to develop a map illustrating the distribution of new patients assessed 
by the renal assessment committee. 
5.7 Ethical considerations 
 
The conduct of this work followed the ethical principles from the World Medical 
Association Declaration of Helsinki.[61] In its retrospective design this audit confers no direct 
risks, burdens or benefits to the patients. Privacy and confidentiality of the subjects were 
protected. The patients’ identity was hidden by use of a code instead of names in the case 
record form. Furthermore the case record forms are stored in the investigators office. Data 
entered is password protected.  
 
Informed consent will not be sought as this is a retrospective audit. And also lack of 
informed consent is justified by the fact that the investigators are part of the therapeutic 
team. The data are not accessed by a third party and hence not a breach of confidentiality. 
Furthermore, it is the obligation of the therapeutic team to ensure justice in the selection 
of patients into the renal replacement program is assured. Hence this audit represents the 
exception in the requirement of informed consent in retrospective studies as described by 
Junod and Elga.[62] 
 
Finally this protocol has ethical approval from the Faculty of Health sciences, Human 








Between January 1st, 2008 and December 31st, 2012 there were 734 patients who were 
assessed for the Groote Schuur Hospital renal replacement program (Figure 1). The trend 
has been of increasing number of patients brought to the assessment meetings over the 5 
years of observation (Figure 2). Overall, 564 patients were new assessments (Figure 1) and 
the trend was towards an increase (Figure 3) in the absolute number of patients accepted 
(p=0.025, χ2 = 11.15). However the number of transplants performed has declined over the 
period of observation (Figure 4). In 2009 there was an increase in transplant which 
corresponded with an increase in the number of accepted patients. 
 
Figure 1: Flow chart of patients assessed for the renal replacement therapy in Groote 
Schuur Hospital 2008-2012. 
 
Figure 2: Graph showing the distribution of patients’ categories according to the year 




-69 Post transplant 
patients 
-43 For transplant only 
-22 Modality change 
-25 Re-assessment 
-11 Appeals 
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Figure 3: A graph showing the distribution of new patients’ outcomes according to the year 
presented (N=564). 
Figure 4: A Graph showing the number of patients who had kidney transplantation at 
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Socio-demographic characteristics of the assessed patients 
The cohort of new patients assessed was composed of fewer blacks compared to non-
blacks (43.1% vs 56.9%) and more males were presented (male to female ratio of 1.3). The 
median age of patients presented was 40yrs with range between 13yrs and 60yrs. Mean of 
39.1. The majority were below the age of 50yrs (n=478, 84.8%). Most patients presented 
were South Africans (n=543, 96.3%) with dependents (n=346, 67.3%).   
 
The presented patients were mostly assessed as compliant (n=425, 78.4%) with no history 
of substance abuse (n=453, 83.6%). The most common substance abused was ethanol 
followed by cannabis.  
 
Even though most were classified as paying patients (n=433, 93.7%), half came from low 
socioeconomic areas (the worse 20% in Cape Town). Overall, there were no significant 
differences in socio-demographic factors before and after introduction of the new 
guidelines (Table 2). 
 
Table 2: Socio-demographic characteristics of new patients presented to the renal 
assessment committee in Groote Schuur from 2008-2012. 








Male gender 116(55.5) 64(62.1) 138(54.8) 1.72 0.42 
Blacks race 84(40.2) 44(42.7) 115(45.6) 1.38 0.50 
Age below 50 years 179(85.6) 88(85.4) 211(83.7) 0.37 0.83 
Mean age (years ± SD) 38.4±10.5 39.8±10.1 39.3±10.8   
Ever married 113(55.4) 54(55.1) 121(52.2) 0.52 0.77 
Unemployed 94(45.4) 51(51.0) 119(51.3) 1.72 0.42 
Foreign nationality 11(5.3) 3(2.9) 7(2.8) 2.2 0.33 
Has Dependents 128(65.6) 69(71.1) 149(67.1) 0.90 0.64 
Overall poor psychosocial assessment 90(45.0) 43(43.9) 123(51.7) 2.67 0.26 
Non-compliance 37(18.1) 20(20.0) 60(25.2) 3.43 0.18 
Substance Abuse 35(17.2) 19(19.0) 35(14.7) 1.08 0.58 
Paying patients 162(92.0) 80(93.0) 191(95.5) 1.99 0.37 
Worse 20% socioeconomic area in Cape 
Town 
85(46.4) 48(54.5) 109(54) 2.7 0.27 
*The χ
2
 and p-value are comparing the time periods. All numbers are patient count unless indicated. 
SD standard deviation 
 
Clinical characteristics of assessed patients 
Most patients were symptomatic with either symptoms of uremia (N=181, 44.4%) or fluid 
overload (N=179, 43.9%) as their major presentation (Table 3). Despite being symptomatic, 
only 20% (N=116) required emergency dialysis. The median serum creatinine concentration 
was 1005.5µmol/L with standard deviation of 674. 
 
The majority of patients had a BMI below 30kg/m2 (N=441, 83.8%) with a median of 24.3 
and a range of 31 (14-45kg/m2). Most tested negative for Hepatitis B surface antigen 
(N=538, 95.4%) and HIV (N=214, 84.9%).  
 
The three presentation periods were clinically comparable in terms of the presentation, 
body mass index, hepatitis B status, emergency dialysis and presence of comorbid diseases. 
However HIV positive patients significantly increased after introduction of the new 
guidelines.  
 
Most of the new patients presented with Hypertension (40.6%), Diabetes (14.4%) or 
chronic Glomerulonephritis (15.8%) as their underlying cause of End Stage Kidney disease 
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(Figure 5). In a significant proportion (15.4%), no underlying etiology was found.  HIVAN 
represented a small proportion 3.5% of the presented patients. Patients with Diabetes 
(Figure 6) were less likely to be accepted (9.2% vs 18.8%) while patients with Chronic 
glomerulonephritis were more likely to be accepted (20%vs12.2%). This difference was 
statistically significant (p=0.008). 
 
Table 3: Clinical characteristics of new patients presented for the renal replacement 
program in Groote Schuur hospital from 2008-2012. 









Major presentation (408) Uremic 90(46.9) 31(43.7) 60(41.4) 8.5 0.198 
Fluid overload 73(38.0) 35(49.3) 71(49.0) 
Body mass index (526) ˃ 30kg/m
2
 36(18.2) 18(18.2) 198(13.5) 2.1 0.357 
HIV status (564) Positive 8(3.8) 11(10.7) 38(15.1) 16 <0.001 
Hepatitis B surface 
antigen (564) 
Positive 6(2.9) 7(6.8) 13(5.2) 2.7 0.255 
Emergency dialysis 
required (563) 
Yes 45(21.6) 20(19.4) 51(20.2) 0.2 0.885 
Renal Disease (564) Diabetes 30(14.4) 15(14.3) 36(14.3) 0.01 0.998 
Number of comorbid 
diseases (564) 
None 132(63.2) 65(63.1) 154(61.1) 3.87 0.694 
1 65(31.1) 32(31.1) 75(29.8) 
2 9(4.3) 4(3.9) 20(7.9) 
3 3(1.4) 2(1.9) 3(1.2) 
*The χ
2
 and p-value are comparing the time periods. All numbers are patient count unless indicated 
**The number cases available for the respective variable. 
 
 
Figure 5: Distribution of main diagnoses of new patients presented to the Renal 
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Figure 6: Comparison of the main renal diagnosis according to the outcome of new patients 






Predicting acceptance into the renal replacement program 
In univariate analysis (Table 4), patients who were black, below 50 years of age and 
employed were found to have a statistically significant association with being accepted into 
the renal replacement program. Other predictors included having dependents, a good 
psychosocial assessment and compliance to treatment. The gender, marital status, 
nationality, socio-economic area and religion were not associated with acceptance into the 
program. Although not statistical significant, there was a tendency of selecting patients 
who can pay (52% vs 34%, p=0.068) 
Diabetes and presence of comorbid diseases had a statistically significant association with 
being rejected by the renal replacement committee. Higher serum creatinine levels, 
hepatitis B positivity, HIV positivity and emergency dialysis at presentation were not 
statistically associated with rejection into the renal replacement program. 
 
However in the multivariate analysis (Table 5), race, compliance to treatment, dependents, 
paying patients and comorbid diseases were no longer predictors. So after multivariate 
analysis, predictors were age above 50 years, unemployment, poor psychosocial 
assessment, substance abuse and diabetic patients. These showed statistical significant 
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Table 4: Univariate analysis of predictors of acceptance into the Renal Replacement 
Program among patients presented in Groote Schuur Hospital from 2008-2012. 
Accepted N (%) Rejected N (%) Χ2 p-value*
Socio-demographic predictors 
Male Gender 144(45.3) 174(54.7) 0.20 0.658 
Black Race 129(53.1) 114(46.9) 8.39 0.004 
Age below 50 233(48.7) 245(51.3) 8.83 0.003 
Ever married 147(51.0) 141(49.0) 2.13 0.145 
Employed 176(64.0) 99(36.0) 59.9 <0.001 
Foreign Nationality 13(61.9) 8(38.1) 2.1 0.139 
Has dependents 177(51.2) 169(48.8) 4.0 0.043 
Poor Psychosocial assessment 48(18.8) 208(81.3) 165 <0.001 
Non-compliant 21(17.9) 96(82.1) 51.9 <0.001 
Substance abuse 15(16.9) 74(83.1) 39.4 <0.001 
Paying patients 225(52.0) 208(48.0) 3.3 0.068 
Worse 20% Socio-economic area 128(52.9) 114(47.1) 1.3 0.252 
Clinical predictors 
Uremic encephalopathy 85(47.0) 96(53.0) 1.5 0.681 
Diabetes Nephropathy 24(29.6) 57(70.4) 10.30 0.001 
Serum Creatinine Above 1001 micromoles/L 128(44.4) 160(55.6) 1.2 0.55 
Body Mass Index Above 30 34(40.0) 51(60.0) 3.10 0.074 
No comorbid disease 191(54.4) 160(45.6) 27.00 <0.001 
Positive Hepatitis B surface antigen 13(50.0) 13(50.0) 0.17 0.683 
HIV Positive 21(36.8) 36(63.2) 2.19 0.139 
Emergency dialysis required 58(50.0) 58(50.0) 0.894 0.344 
*The χ
2
 and p-value evaluates the two outcomes.
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Table 5: Multivariate analysis of predictors of acceptance by the Renal Replacement 
committee among new patients presented in Groote Schuur Hospital from 2008-2012. 
Predictor B Wald χ
2




Black Race 0.114 0.171 0.679 1.121 0.653 1.925 
Age above 50yrs -1.367 10.398 0.001 0.255 0.111 0.585 
Unemployment -1.171 19.375 <0.001 0.310 0.184 0.522 
Lack of Dependents -0.161 0.334 0.563 0.851 0.494 1.469 
Poor Psychosocial Assessment -2.066 49.232 <0.001 0.127 0.071 0.226 
Compliance History 0.625 2.911 0.088 1.868 0.911 3.827 
Substance Abuse -1.755 19.334 <0.001 0.173 0.079 0.378 
Paying patient 0.155 0.069 0.793 1.167 0.368 3.705 
Diabetic Patients -0.989 5.839 0.016 0.372 0.167 0.830 
Comorbid Disease/s -0.359 1.585 0.208 0.699 0.400 1.221 
 
Effect of prioritization criteria 
The introduction of prioritization criteria has not led to changes in outcomes of the 
assessments. The committee remained consistent in classifying patients (Table 6) in that 
there was no difference in the proportion of patients classified as either category 1, 2 or 3 
after the use of prioritization criteria (p=0.98). Before the new criteria, only 2 category 1 
patients did not receive renal support (Figure 7). The number of unsupported category 2 
patients is higher (22 patients). In overall, even if accepted, almost one third 27.4% 
(58/212) of category two patients did not get onto the program (Figure 8). The prioritization 
criteria did not increase the proportion of category 2 patients who joined the program 
(p=0.5). In totality, although the absolute number of patients accepted increased (Figure 7), 
no change in the proportion of patients who were accepted was noted (p=0.77). 
It is noteworthy that there were more HIV positive patients accepted into the programme 
after introduction of the prioritization criteria (2%vs13.9%, p=0.006). All other socio-
demographic and clinical variables did not reveal any statistical significant differences 
between the assessment periods. 
Table 6: Characteristics of Patients assessed by the renal replacement committee before 
and after the use of Prioritization Criteria (N=564). 







Category 1 26(12.4) 15(14.6) 31(12.3) 0.45 0.98 
Category 2 79(37.8) 39(37.9) 94(37.3) 
Category 3 104(49.8) 49(47.6) 127(50.4) 
Accepted patients 100(47.8) 45(43.7) 115(45.6) 0.52 0.77 
Accepted HIV Positive 8(3.8) 11(10.7) 38(15.1) 15.97 <0.001 
*The χ
2
 and p-value evaluate the presentation periods. 
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Figure 7: Bar chart showing the proportion of patients presented in each assessment 
periods according to prioritization category (N=564). 
Bar chart showing the proportion of patients presented in each assessment periods 
according to prioritization category (N=564). 
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This audit describes the outcome of patients assessed for the Renal Replacement Therapy 
(RRT) program and explores the extent to which equity in selection of patients onto the 
program is achieved. A total of 564 new patients were presented to the RRT committee 
between 2008 and 2012. The average presented patient profiles a potential productive 
South African citizen i.e. 40yrs male with dependents and classified as able to pay 
subsidized hospital bills (Table 3). Noting that over half (N=304, 53.9%) were rejected by 
the committee, this represents in addition, a significant economic loss to the families and 
South Africa as a whole. These findings seem, at first instance, to negate the principle of 
utilitarianism. This refers to maximizing the benefit that the society will get from allocation 
of treatment. Utilitarianism is a criterion for selection of patients according to the current 
guideline.[9] However reference is made to transplantation rather than to dialysis treatment 
in these guidelines. The patients turned down had less favorable characteristics for kidney 
transplantation. This is unfortunately the cost of maintaining a RRT program in a resource 
limited setting. 
 
The high cost  of renal replacement therapy[63] combined with the rising burden of chronic 
kidney disease[2][14] has placed a strain on health systems globally. In Africa, the unmet need 
for managing ESKD is likely underestimated due to the obvious lack of data.[63] In countries 
with well-established government funded programs like South Africa, only about 12.5% of 
the dialysis need is met.[9] The success of the dialysis program in South Africa also stems 
from incorporating transplantation as a pre-requisite for treating patients. 
 
One may predict with confidence that such a deficit in the dialysis slots available, is going to 
increase. The population in South Africa’s increased by 10 million in 18 years yet there was 
an addition of only 2 dialysis units in the public sector.[19] In this audit the number of new 
patients presented to the Groote Schuur Renal Replacement Committee between 2008 and 
2012 increased (Figure 2, 3 and 4). This, coupled by a decrease in the number of transplants 
(Figure 5) will continue to place strain on the available dialysis slots. And during this period 
only 46% (N=260) of 564 patients could be accepted onto the program (Table 2). A similar 
proportion of patients (47%) were accepted in an earlier series at Tygerberg Hospital, 
another Western Cape hospital.[8] This similarity might be due to the predominance of 
psychosocial criteria used to select patients in both series. 
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Even though in both series age and employment status were both prominent decisive 
factors, Moosa et.al., had more whites being selected than blacks.[8] This is in contrast to 
our results which document more blacks being accepted than non-blacks in univariate 
analysis. However in multivariate analysis, race is not a predictor for acceptance onto 
treatment. One may hypothesize that the disparities in access to health have improved 
over the years in alignment with the government’s policy to provide health care for all. The 
South African renal registry data support this hypothesis as the proportion of black South 
Africans on dialysis has increased from 31.2% in 1994 to 51.2% in 2012.[19] This is 
unfortunately not entirely accurate, as several reports[64][65] have continued to document 
the inequality in access to health in the new South Africa. However these results show an 
encouraging trend 20yrs after demise of the apartheid system. Our results may reflect the 
similarities in socio-economical characteristics among the uninsured South Africans 
attending a state sponsored hospital. Disparities in access to health, particularly in those 
uninsured is not a local phenomenon but rather a global concern.[14][63] 
Disparity in selecting patients based on employment status has been previously reported in 
South Africa.[8] Unemployment was an important predictor of being rejected from the renal 
replacement therapy program at Groote Schuur. This is no longer a discriminatory factor in 
the current Western Cape guidelines (Appendix 2). Despite this, the guidelines may still 
negatively affect unemployed candidates. Acceptance onto the program requires evidence 
of financial means to regularly arrange for transport to the renal unit, which is part of the 
criteria. About two thirds (68% of 257 accepted patients) were employed in our cohort. In 
contrast to our findings only 11.4% of 290,252 patients being prepared for ESKD care in the 
United States were employed.[66] 
Other socio-demographic factors such as gender, marital status, nationality and area of 
residence were not predictors of acceptance among presented patients. This adds strengths 
to the use of current guidelines which do not discriminate against these groups. 
Inadequate access to health care probably explains another finding in our audit. The 
majority of patients presented to our RRT program were in advanced disease stages, forty 
four percent (N=181) had uremic symptoms and more than half had a serum creatinine 
concentration above 1000µmol/L (Table 4). Patients who are socioeconomically 
disadvantaged tend to present late to a nephrologist [67][68] and have less than optimal 
outcome on treatment.[69] This is consistent with the advanced presentation of patients in 
our series, as over half of the presented patients 51% (N=242) came from the lowest 
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socioeconomic areas of Cape Town. This work indirectly reveals the challenges in the 
current health system of the Western Cape. 
 
The difficulty in early diagnosis was also seen in HIV positive patients. In our cohort, HIV 
positive patients were under-represented.  HIV positive patients accounted for only 10% of 
all new patients presented to the selection committee. Similarly in a study looking at the 
outcomes of rationing among ESKD patients at Groote Schuur Hospital (GSH), only 12.5% 
had HIVAN.[4] The number of HIV patients in these cohorts is likely lower than expected. 
This assumption is based on another GSH study which showed that 44% of all patients with 
Nephrotic syndrome had HIVAN. And particularly because these HIVAN patients had 
severely impaired renal function.[70] Under representation of HIV positive patients arises 
from the fact that most had outright exclusion criteria. In other words, they had 
uncontrolled HIV disease. One may infer that this demonstrates the challenges of early 
diagnosis and treatment of HIV in South Africa. Early diagnosis and management of HIV 
would allow more HIV positive candidates to be considered for dialysis and transplantation. 
It should be noted that HIV status was not a predictor of acceptance onto the program 
among new patients presented (Table 6). 
 
New guidelines for selection were introduced in 2010. The impact of their use at Groote 
Schuur was examined in this work. There was a trend towards increased HIV positive 
patients being accepted (Table 8). This finding likely represents the increase in burden, as 
stable HIV positive patients were accepted since 2009. The absolute number of patients 
accepted increased between 2008 and 2012 (p=0.025) but when the implementation 
periods were compared no difference was noted (Figure 3, Table 8). This is because during 
the year 2009 there was an abrupt increase in the number transplants associated with 
increased acceptance rates. In overall, the trend was towards increased acceptance rates in 
keeping with the prioritization policy. This policy, which allows for the best candidates 




The retrospective study design depended on available reports which had some missing 
data. A detailed record of the socio economic status of patients could not be described. 
These results may not be generalized to the whole South African population because there 
is a significant dialysis population in the private sector. The private sector has a different 
population distribution compared to the state dialysis patients. 
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8.0 Conclusion and Recommendations 
Twenty years after the end of apartheid, South Africa has made improvements in disparities 
to access of dialysis despite resource challenges. In the setting of resource limitation, 
rationing of dialysis becomes unavoidable in running a sustainable program. Efforts to 
allocate more resources should continue in view of the loss of young and potential 
productive life. Advanced presentation of patients with ESRD represents challenges in early 
diagnosis and referral in the current system. Community screening programs and improved 
access to knowledgeable clinicians at the primary level is advocated. The use of new 
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Appendixes 
Appendix 1 Case Record Form 
Characteristics and outcomes of patients assessed for the renal replacement therapy at 
Groote Schuur Hospital. 
PART 1: Demographics S/No:  …………………… ID code…………………….. 
Age Sex Male/Female/Unknown 




PART2: Clinical characteristics 
P/Complaint BMI 
Serology:    HIV(CD4)  
HBSag   CMV 
Main Diagnosis and Co morbidities 
Late Referral yes/no 
Referring institute 
Eligibility for Kidney transplantation 
Contraindication absent or present 
PART3: Other Social Characteristics 
Home conditions: Favorable/unfavorable 
Social Support: Adequate/Inadequate 
Insight: strong/weak 
History of Noncompliance to treatment y/n 
Substance Abuse:  yes/no 
Type and Duration ………………………………….. 





Acceptance yes/no Appeal : yes/no    Outcome of appeal: 
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Appendix 2: Prioritization Policy 
The Western Cape Government has drawn up guidelines to prioritize eligibility into the 
renal replacement programs (3). The following are the criteria used to categorize patients. 
All patients in whom the diagnosis of end-stage or advanced chronic kidney disease is made 
will undergo formal assessment. This process will stream patients into 3 groups: 
Category 1. Patients with this priority rating must be accommodated on the dialysis 
and transplant programme. Resources will always be found to treat these patients. 
Category 2. Patients with this priority rating will be accommodated on the 
programme only if resources allow, with priority to the category 2 patients waiting 
the longest and who have the best chance of good outcomes.  
Category 3. Patients in Category 3 will be offered optimal conservative treatment, 
are not eligible for Categories 1 or 2 and will not be offered renal replacement 
therapy  
Category 1: 
Patients in this category are considered to potentially have the best possible outcome and 
would derive maximum benefit with the lowest risk of treatment failure. In addition to 
meeting the relevant requirements of Category 2 (and not been excluded by any Category 3 
factor), a patient in this category must be assessed against, and meet the following 
constellation of factors: 
o Age. 50 years;
o BMI less than 30 kg/m2;
o HIV negative;
o Hepatitis B Surface Antigen (HBSag) negative.
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These factors, taken together and considering the patients overall medical condition, will 
guide the decision on selecting patients for Category 1. 
Category 2: 
Patients in this category may be eligible for treatment provided resources allow. The 
following factors improve a patient’s chance of being offered treatment: 
Social Factors 
 Good home circumstances (including access to storage space, running water, 
sanitation and electricity), needed to succeed with dialysis and transplantation; 
 The patient is well-motivated and has access to a good social support system 
required to do well on dialysis and transplantation, and Proximity to and/or 
evidence of financial means or other capability to regularly arrange transport to a 
Renal unit as frequently as this may be needed (the unit is unable to pay for or 
provide such transport). 
The following factors, taken together, reduce the chances of being offered treatment: 
Medical Factors 
 Above age 50 years; 
 BMI 30-35 kg/m2; 
 Hypertension with severe left ventricular dysfunction or other severe target organ 
damage; 
 HBSag/HCV positive with no cirrhosis; 
 Smoking; 
 Diabetes mellitus; 
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 HIV+ patients whose CD4+ T cell count. 200/ml, have an undetectable viral load 
and, if on antiretroviral (ARV) treatment, demonstrated good adherence and 
clinical response within 6 months; 
 First presentation with ESKF requiring urgent dialysis; 
 Comorbid disease e.g. stable ischemic heart disease; 
 Previous kidney transplant. 
These factors, taken together and considering the patients overall medical condition, will 
guide the decision on offering treatment but no single factor will automatically exclude 
patients from treatment. The extent to which patients have properties that resemble those 
of category one patients, the greater the likelihood that they will be accepted; conversely 
the greater the number of unfavorable factors the lower chances of acceptance. 
Category 3 
Kidneys are a very scarce resource and should be allocated to patients who will derive most 
benefit from the transplant. Any condition or circumstance which compromises the 
medium-long term survival of a patient or the graft will exclude the patient from 
transplantation and selection for Category 2 or Category 1. 
Any one of the following factors excludes patients: 
 Renal transplantation is contraindicated or carries unacceptable risks; 
 AIDS or HIV infection other than HIV+ patients with the medical characteristics 
described in category 2; 
 Age 60 years; 
 Active substance abuse or dependency; 
 Morbid obesity (BMI . 35 kg/m2); 
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 HBeAg positive or cirrhosis; 
 Diabetes mellitus and aged >50 years; 
 Active, uncontrollable malignancy with short life expectancy; 
 Advanced, irreversible progressive disease of vital organs such as: 




 Psychological Exclusion Criteria 
o Any form of serious mental illness or incapacity which, as shown by psychiatric and
medical examination, would preclude the patient and/or family or available support group 
from successfully managing the patient, considering his/her impairment, through dialysis, a 
transplant, and extended follow up care; 
 Habitual Non-Adherence 
o Patients with habitual non-adherence to any medical treatment.
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Appendix 3: Ethical Approval Letter 
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Appendix 4 GSH Clinicom database access permission 
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Appendix 5:  The 2008 Groote Schuur Renal Replacement Assessment Tool. 
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Appendix 6: Psychosocial Assessment 
